Total Payments
$1,889
2024 Payments
$281.75
Companies
16
Transactions
51
Medicare Patients
1,261
Medicare Billing
$321,887
Payment Breakdown by Category
Food & Beverage$1,889 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,889 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $439.73 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $354.97 | 9 | $0 (2024) |
| PFIZER INC. | $245.23 | 3 | $0 (2017) |
| Merck Sharp & Dohme LLC | $176.73 | 7 | $0 (2023) |
| Allergan Inc. | $172.20 | 5 | $0 (2019) |
| Chiesi USA, Inc. | $115.22 | 7 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, LLC | $105.70 | 1 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $95.96 | 1 | $0 (2022) |
| Melinta Therapeutics, LLC | $40.86 | 3 | $0 (2023) |
| CSL Behring | $29.39 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $281.75 | 17 | Chiesi USA, Inc. ($115.22) |
| 2023 | $109.26 | 7 | AstraZeneca Pharmaceuticals LP ($32.84) |
| 2022 | $605.42 | 9 | La Jolla Pharmaceutical Company ($332.20) |
| 2021 | $78.27 | 1 | La Jolla Pharmaceutical Company ($78.27) |
| 2020 | $105.70 | 1 | PORTOLA PHARMACEUTICALS, LLC ($105.70) |
| 2019 | $49.62 | 4 | Allergan Inc. ($37.80) |
| 2018 | $134.40 | 2 | Allergan Inc. ($134.40) |
| 2017 | $524.93 | 10 | PFIZER INC. ($245.23) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $14.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/15/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 10/02/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/19/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: VTE | ||||||
| 09/04/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/06/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 04/11/2024 | Masimo Corporation | SedLine (Device) | Food and Beverage | Cash or cash equivalent | $16.26 | General |
| Category: Devices | ||||||
| 03/26/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 03/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/01/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 01/26/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/17/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Rare Disease | ||||||
| 10/02/2023 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Orbactiv | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: ANTIFUNGALS | ||||||
| 08/19/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/24/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Rare Disease | ||||||
| 05/22/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.99 | General |
| 04/10/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/19/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $70.76 | General |
| Category: EMERGENT HYPOTENSION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 349 | 567 | $518,719 | $81,042 |
| 2022 | 6 | 218 | 370 | $293,401 | $55,750 |
| 2021 | 9 | 331 | 543 | $356,058 | $77,171 |
| 2020 | 8 | 363 | 713 | $506,146 | $107,924 |
Total Patients
1,261
Total Services
2,193
Medicare Billing
$321,887
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 144 | 338 | $406,215 | $60,923 | 15.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 62 | 78 | $33,593 | $7,918 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 46 | $38,331 | $6,645 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $14,846 | $2,892 | 19.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 22 | 22 | $20,068 | $1,555 | 7.7% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 16 | 17 | $3,065 | $630.72 | 20.6% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 34 | 40 | $2,602 | $478.20 | 18.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 114 | 255 | $248,750 | $45,902 | 18.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $15,335 | $3,676 | 24.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 35 | $12,433 | $2,907 | 23.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 16 | 21 | $8,586 | $1,978 | 23.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 14 | 14 | $5,415 | $1,016 | 18.8% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 20 | 23 | $2,881 | $270.70 | 9.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 121 | 297 | $270,695 | $56,224 | 20.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 62 | 89 | $30,462 | $7,751 | 25.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 31 | $20,645 | $5,126 | 24.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 24 | 26 | $10,483 | $2,486 | 23.7% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 14 | 15 | $6,971 | $1,852 | 26.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 25 | $5,976 | $1,562 | 26.1% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 18 | 18 | $5,107 | $1,325 | 25.9% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 13 | 13 | $1,882 | $498.94 | 26.5% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 27 | 29 | $3,837 | $348.00 | 9.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 160 | 459 | $418,346 | $87,012 | 20.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 73 | 107 | $36,623 | $9,532 | 26.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 30 | 38 | $15,322 | $3,679 | 24.0% |
About Jacob Mathew, M.D., PHARM.D
Jacob Mathew, M.D., PHARM.D is a Internal Medicine healthcare provider based in Livingston, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407160187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacob Mathew, M.D., PHARM.D has received a total of $1,889 in payments from pharmaceutical and medical device companies, with $281.75 received in 2024. These payments were reported across 51 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,889).
As a Medicare-enrolled provider, Mathew has provided services to 1,261 Medicare beneficiaries, totaling 2,193 services with total Medicare billing of $321,887. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Livingston, NJ
- Active Since 08/04/2010
- Last Updated 02/21/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407160187
Products in Payments
- GIAPREZA (Drug) $439.73
- ANDEXXA (Biological) $342.52
- AVYCAZ (Drug) $172.20
- ELIQUIS (Drug) $162.53
- ZERBAXA (Drug) $149.46
- BRILINTA (Drug) $118.15
- CLEVIPREX (Drug) $115.22
- CHANTIX (Drug) $100.00
- RELISTOR (Drug) $95.96
- Kcentra (Biological) $29.39
- Vabomere (Drug) $27.48
- FLOWTRIEVER CATHETER, S (Device) $23.45
- DIFICID (Drug) $17.86
- XARELTO (Drug) $16.34
- SedLine (Device) $16.26
- Rezzayo (Drug) $13.38
- Fetroja (Drug) $13.22
- CUBICIN RF (Drug) $9.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Livingston
Dr. Fariborz Rezai, M.d, M.D
Internal Medicine — Payments: $2.7M
Internal Medicine $2.7M
Dr. Martin Bedigian, Md, MD
Internal Medicine — Payments: $894,400
Internal Medicine $894,400
Dr. Sridhar Nambi, Md, MD
Internal Medicine — Payments: $152,292
Internal Medicine $152,292
Dr. Noah Rosenberg, Md, MD
Internal Medicine — Payments: $148,109
Internal Medicine $148,109
Dr. Bruce Haik, M.d, M.D
Internal Medicine — Payments: $32,109
Internal Medicine $32,109
Dr. Anna Litvak, Md, MD
Internal Medicine — Payments: $21,218
Internal Medicine $21,218